Search results
Short Call: Bull case for realty stocks, US commercial property market, Asian Paints, Dixon, Coal...
CNBC Awaaz· 10 hours agoIn investing, being a cheapskate, and not paying up, helps – a lot. Joel Tillinghast
Zensar acquires BridgeView to expand into biopharma, life sciences industry
Business Standard India· 17 hours agoPune-headquartered IT company Zensar Technologies announced the acquisition of pharma and life...
Zydus announces licensing deal with Takeda for new GERD drug Vault
Business Standard India· 22 hours agoGlobal life sciences company Zydus Lifesciences has entered into a licensing agreement with Takeda...
Exposure to India's infra sector helps LIC, SBI outshine peers - The Economic Times
The Economic Times· 24 hours agoShares of state-owned behemoth Life Insurance Corporation (LIC) have outperformed rivals like HDFC ...
Exposure to India's infra sector helps LIC, SBI outshine peers - ET BFSI
The Economic Times· 1 day agoLIC's stock has gained nearly 79 per cent from Rs 620 on July 18, 2023, to Rs 1,109.15 at the...
How state-owned LIC shares outperformed rivals HDFC Life and ICICI Prudential Life
The Week· 1 day agoPublic sector heavyweight Life Insurance Corporation (LIC) of India has outperformed its rivals in...
Exposure to India's infra sector helps LIC, SBI outshine peers | Business Insider India
Business Insider India· 1 day agoLIC's stock has gained nearly 79% from Rs 620 on June 18, 2023, to Rs 1,109.15 at the closing on...
Cement companies are going green, but meaningful change will take time
Livemint· 1 day agoThe brokerage house estimates the share of green energy in the sector’s total power consumption will...
Mutual Funds: These stocks were the top additions of MF houses on their portfolios. Check details
Business Today· 1 day agoMutual Fund investment: The latest data from the Association of Mutual Funds in India (AMFI)...
Buy 360 One WAM; target of Rs 1150: Motilal Oswal
CNBC Awaaz· 1 day agoMotilal Oswal is bullish on 360 One WAM recommended buy rating on the stock with a target price of Rs 1150 in its research report dated July 16, 2024.